MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

Clinical trial NCT07463651 · RECRUITING

Trial details

NCT number: NCT07463651
Sponsor: The First Affiliated Hospital of Soochow University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)FLT3-ITD Mutation Allogeneic Hematopoietic Cell Transplantation (HCT)Maintenance Therapy Gilteritinib Sorafenib

Start date: 2026-05-01
Primary completion: 2028-05-31
Enrollment: 594

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.